TrialScientific reports2021

Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma.

Yeon Jeong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.